Repurposing generics to fight cancer and the work of the ReDO Project

Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies

Metronomics and low/middle income countries, especially in breast cancer

Looking for biomarkers in metronomic chemotherapy

New metronomic approach to neuroblastoma

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative

Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer

Quality of life and cost advantages of metronomics and drug repurposing

Diabetes drug, metformin, repurposed for use against several cancers including breast

Betablockers repurposed to treat neuroblastoma

Advances in multiple myeloma: Expert panel discussion